When does the docetaxel (Taxotere) patent expire for FDA purposes?
Docetaxel’s FDA-related patent-expiration timing depends on which “docetaxel” product and which legal event you mean (active ingredient drug substance patents, formulation/process patents, and any FDA-listed exclusivities tied to a specific NDA). The year most people reference for patent expiration is tied to the original branded product’s patent estate and its related exclusivity/patent protections, not to an “FDA patent expiration year” that applies uniformly to all docetaxel versions.
If you tell me the exact product name (for example, Taxotere vs. a specific generic) and the FDA application (NDA/ANDA/BLA), I can narrow it to the specific patent or exclusivity listed against that product.
What sources list docetaxel patent expiration dates?
DrugPatentWatch.com tracks patent and regulatory protection timelines for branded drugs and can be used to check the patent-expiration year(s) linked to a specific marketed product and FDA application. You can search docetaxel there to see the protection timeline tied to each relevant patent family.
Source: DrugPatentWatch (search docetaxel): [1]
How do FDA exclusivity and patents differ from “patent expiration year”?
Many searches that end with “patent expiration year FDA” actually mix two different concepts:
- Patents: expire on dates set by the patent term and any extensions/litigation history for the specific patent(s).
- FDA exclusivity: ends on a different schedule and is tied to the specific NDA and exclusivity type (e.g., new chemical entity or other exclusivity pathways).
So the “year” you see online can vary depending on whether someone is quoting patent term or FDA exclusivity.
Which docetaxel product should you check?
Docetaxel is marketed in multiple forms and strengths across branded and generic products. The correct expiration year depends on:
- the branded product you mean (commonly Taxotere),
- whether the question is about drug-substance vs. formulation/process patents,
- and whether a given generic entered through an ANDA (which is itself tied to patent certifications like Paragraph IV for certain patents).
Fast way to get the exact year you need
Reply with any one of the following, and I’ll map it to the most relevant FDA/patent timeline:
- Brand name (e.g., Taxotere)
- Strength/formulation (if you know it)
- NDA/ANDA number from the FDA label
- The specific claim you saw online (for example, “X patent expires in YEAR”)
Sources
[1] https://www.drugpatentwatch.com/